Endometriosis
📧 Sign up to get email alerts when something new happens for Endometriosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-05-19FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Meitheal Pharmaceuticals Inc)
FDA approved a supplemental application for leuprolide acetate from Meitheal Pharmaceuticals Inc, related to the existing approval for this …
-
FDA approval · 2017-05-19FDA Approved: SYNAREL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Synarel (nafarelin acetate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2017-01-13FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
The FDA approved a supplemental application for VABRINTY (leuprolide acetate) submitted by URONOVA PHARMACEUTICALS, INC., resulting in label…
-
FDA approval · 2016-02-29FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) submitted by URONOVA Pharmaceuticals.
-
FDA approval · 2015-05-08FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Leuprolide acetate submitted by Sun Pharmaceutical Industries, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-01-20FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc. The action expands the product's…
-
FDA approval · 2014-10-10FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA Pharmaceuticals.
-
FDA approval · 2014-10-07FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
The FDA approved a supplemental application for ZOLADEX (goserelin) filed by TerSera Therapeutics LLC. This action typically updates labelin…
-
FDA approval · 2014-07-18FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approves a supplemental application for VABRINTY (leuprolide acetate) submitted by Uronova Pharmaceuticals, Inc. The approval updates th…
-
FDA approval · 2014-03-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc.
-
FDA approval · 2013-04-25FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approves Verity Pharmaceuticals' supplemental application for TRELSTAR (triptorelin pamoate).
-
FDA approval · 2013-04-11FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., resulting in a label update und…
-
FDA approval · 2013-03-12FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) from Verity Pharmaceuticals Inc., indicating an updated labeling …
-
FDA approval · 2013-02-27FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) submitted by Uronova Pharmaceuticals, Inc. The approval pertains t…
-
FDA approval · 2013-02-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) by URONOVA Pharmaceuticals.
-
FDA approval · 2012-03-19FDA Approved: DANAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for danazol from Teva Pharmaceuticals USA, Inc. The approval updates the drug's labeling and/or indi…
-
FDA approval · 2012-01-23FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Lupron Depot (leuprolide acetate) from AbbVie, resulting in an updated approval and labeling for…
-
FDA approval · 2011-06-14FDA Approved: LUPRON DEPOT — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for LUPRON DEPOT (leuprolide acetate) by AbbVie, expanding its approved indications and labeling.
-
FDA approval · 2011-04-26FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Leuprolide Acetate from Sun Pharmaceutical Industries, resulting in changes to the product's…
-
FDA approval · 2011-04-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) filed by Uronova Pharmaceuticals. This action approves the supplem…
-
FDA approval · 2011-03-28FDA Approved: LEUPROLIDE ACETATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application from Sandoz Inc. for Leuprolide acetate (ANDA 074728).
-
FDA approval · 2010-10-15FDA Approved: MEDROXYPROGESTERONE ACETATE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Medroxyprogesterone Acetate submitted by Prasco Laboratories.
-
FDA approval · 2010-10-05FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) by URONOVA PHARMACEUTICALS, INC.
-
FDA approval · 2009-03-09FDA Approved: LEUPROLIDE ACETATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Leuprolide acetate from Sun Pharmaceutical Industries as an original application (generic) for multiple hormone-related indicat…
-
FDA approval · 2007-11-08FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA PHARMACEUTICALS, INC., signaling an expanded/updated …